In the pre-cART era, the risks of developing an initial episode of PCP in patients with CD4 counts of less than 200 cells/mm3 by six, 12 and 36 months were 13%, 24% and 39%, respectively [11]. The gene discussed is CD4; the disease is pneumocystosis.